ECSP056091A - Proceso para la preparacion del analogo de ciclosporina a - Google Patents

Proceso para la preparacion del analogo de ciclosporina a

Info

Publication number
ECSP056091A
ECSP056091A EC2005006091A ECSP056091A ECSP056091A EC SP056091 A ECSP056091 A EC SP056091A EC 2005006091 A EC2005006091 A EC 2005006091A EC SP056091 A ECSP056091 A EC SP056091A EC SP056091 A ECSP056091 A EC SP056091A
Authority
EC
Ecuador
Prior art keywords
preparation
cyclosporin
cyclosporine analog
analogue
formula
Prior art date
Application number
EC2005006091A
Other languages
English (en)
Inventor
Jean-Michel Adam
Mark Abel
Seetharaman Jayaraman
Original Assignee
Isotechnika Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isotechnika Inc filed Critical Isotechnika Inc
Publication of ECSP056091A publication Critical patent/ECSP056091A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El presente invento se relaciona con un nuevo proceso para la preparación de análogo de la ciclosporina A de la formula I: que comprende los pasos de, a) alicatar un aldehído protegido de ciclosporina A con un reactivo alilmetálico y, b) transformar el compuesto obtenido en el paso a) al análogo de la ciclosporina A de la fórmula I.
EC2005006091A 2003-04-08 2005-10-07 Proceso para la preparacion del analogo de ciclosporina a ECSP056091A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03007921 2003-04-08

Publications (1)

Publication Number Publication Date
ECSP056091A true ECSP056091A (es) 2006-03-01

Family

ID=33155122

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006091A ECSP056091A (es) 2003-04-08 2005-10-07 Proceso para la preparacion del analogo de ciclosporina a

Country Status (18)

Country Link
US (1) US20040220091A1 (es)
EP (1) EP1613646A2 (es)
JP (1) JP2006525961A (es)
KR (1) KR20050119200A (es)
CN (1) CN1798759A (es)
AU (1) AU2004228159A1 (es)
BR (1) BRPI0409734A (es)
CA (1) CA2521116A1 (es)
CO (1) CO5680450A2 (es)
EC (1) ECSP056091A (es)
MA (1) MA27831A1 (es)
MX (1) MXPA05010794A (es)
NO (1) NO20054478L (es)
RU (1) RU2005130508A (es)
TN (1) TNSN05255A1 (es)
TW (1) TW200505946A (es)
WO (1) WO2004089960A2 (es)
ZA (1) ZA200507980B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6859799B1 (en) 1998-11-30 2005-02-22 Gemstar Development Corporation Search engine for video and graphics
US7103906B1 (en) 2000-09-29 2006-09-05 International Business Machines Corporation User controlled multi-device media-on-demand system
KR100946318B1 (ko) 2000-10-11 2010-03-09 유나이티드 비디오 프로퍼티즈, 인크. 데이터의 기억 장치를 주문형 매체 배달 시스템의 서버에제공하기 위한 시스템 및 방법
US7493646B2 (en) 2003-01-30 2009-02-17 United Video Properties, Inc. Interactive television systems with digital video recording and adjustable reminders
JP2006524232A (ja) 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US7799756B2 (en) * 2004-07-29 2010-09-21 Albany Molecular Research, Inc. Processes for stereoselective synthesis of trans ISATX247
US8086575B2 (en) 2004-09-23 2011-12-27 Rovi Solutions Corporation Methods and apparatus for integrating disparate media formats in a networked media system
EP1804823A4 (en) 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
JP2008514701A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
KR100780718B1 (ko) 2004-12-28 2007-12-26 엘지.필립스 엘시디 주식회사 도포액 공급장치를 구비한 슬릿코터
US8607287B2 (en) 2005-12-29 2013-12-10 United Video Properties, Inc. Interactive media guidance system having multiple devices
US9681105B2 (en) 2005-12-29 2017-06-13 Rovi Guides, Inc. Interactive media guidance system having multiple devices
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US20090019492A1 (en) 2007-07-11 2009-01-15 United Video Properties, Inc. Systems and methods for mirroring and transcoding media content
US8435544B2 (en) 2007-10-08 2013-05-07 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
US8601526B2 (en) 2008-06-13 2013-12-03 United Video Properties, Inc. Systems and methods for displaying media content and media guidance information
FR2934997B1 (fr) * 2008-08-14 2010-09-24 Minakem Derives cyclopropyl-et cyclobutyl-dioxazaborocanes ou dioxazaborecanes
WO2010144194A1 (en) 2009-06-09 2010-12-16 Lux Biosciences, Inc. Topical drug delivery systems for ophthalmic use
US9014546B2 (en) 2009-09-23 2015-04-21 Rovi Guides, Inc. Systems and methods for automatically detecting users within detection regions of media devices
JP6144627B2 (ja) 2010-12-15 2017-06-07 コントラヴィア ファーマシューティカルズ、インク． アミノ酸１および３で修飾されたシクロスポリン類似体分子
US8805418B2 (en) 2011-12-23 2014-08-12 United Video Properties, Inc. Methods and systems for performing actions based on location-based rules
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
US9674563B2 (en) 2013-11-04 2017-06-06 Rovi Guides, Inc. Systems and methods for recommending content
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
EP4201952A1 (en) 2021-12-21 2023-06-28 Curia Spain, S.A.U. Process for the controlled synthesis of voclosporin
WO2025119925A1 (en) 2023-12-05 2025-06-12 Medichem, S.A. Process for preparing voclosporin
IT202300028041A1 (it) * 2023-12-27 2025-06-27 Indena Spa Processo per la preparazione di voclosporina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
AU7267298A (en) * 1997-04-30 1998-11-24 Regents Of The University Of California, The Synthesis of discodermolide and analogs
AU750245B2 (en) * 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
DE10143979A1 (de) * 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
ES2310604T3 (es) * 2001-10-19 2009-01-16 Isotechnika, Inc. Mezclas de analogos de ciclosporinas y su uso como agentes inmunomoduladores.
WO2003033526A2 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs

Also Published As

Publication number Publication date
AU2004228159A1 (en) 2004-10-21
TNSN05255A1 (en) 2007-07-10
WO2004089960A2 (en) 2004-10-21
MA27831A1 (fr) 2006-04-03
NO20054478D0 (no) 2005-09-28
WO2004089960A3 (en) 2005-01-06
RU2005130508A (ru) 2006-06-27
BRPI0409734A (pt) 2006-05-09
CN1798759A (zh) 2006-07-05
NO20054478L (no) 2005-10-17
CA2521116A1 (en) 2004-10-21
ZA200507980B (en) 2006-11-29
EP1613646A2 (en) 2006-01-11
KR20050119200A (ko) 2005-12-20
MXPA05010794A (es) 2005-12-14
CO5680450A2 (es) 2006-09-29
TW200505946A (en) 2005-02-16
JP2006525961A (ja) 2006-11-16
US20040220091A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
BRPI0606339A2 (pt) formas farmacêuticas resistentes a álcool
PY09026846A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
TW200731094A (en) Extensible meta-data
TW200505946A (en) Process for preparation of cyclosporin a analog
ATE528989T1 (de) Kristalline feste rasagilin-base
ECSP099721A (es) Inhibidores de cinasa p70 s6
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
BRPI0509184A (pt) composições farmacêuticas
UY28745A1 (es) Nuevos compuestos
HN2011001247A (es) Inhibidores de cinana akt y p70 s6
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
ECSP099616A (es) Estabilización de vitamina b12
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
BRPI0408848B8 (pt) composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
CL2009001342A1 (es) Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c; preparados farmaceuticos que lo contienen; compuesto 11 alfa-hidroxi-15 beta, 16 beta-metilen-androst-4-en-3,17-diona; procedimiento para preparar dicho compuesto que comprende el uso de microorganismos.
GT200500358A (es) Compuestos organicos
UY30555A1 (es) Formulacion aerosol para la inhalacion de beta-agonistas
BRPI0713343A2 (pt) Composições farmacêuticas contendo anticorpo monoclonal anti-idiolípico anti-ca-125 e alumínio
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen
CR8946A (es) Fenoles de carbonilo fenantridina como moduladores de citoquina